He joined the FDA in 2023 as an Oak Ridge Institute for Science and Education (ORISE) Fellow with the Clinical Safety and Human Subject Research Team in the Division of Therapeutic Performance II (DTP II), Office of Research and Standards (ORS), under the Office of Generic Drugs (OGD) and is currently working as a contractor for the same team
We serve universities, private biotech firms, and independent research labs across multiple global regions reliably
Santos CXC, Raza S, Shah AM
BPC-157 at the dominant 50mg concentration anchors the cytoprotective and pro-angiogenic research
Anti-MAdCAM-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease
And I was working hard in my clinic in Portland and was mentored up by one of the best for several decades and closed down my practice right before COVID hit, thankfully